EVIDENCE-BASED NUTRITION PATTERNS AND LIFESTYLE COUNSELLING IN TYPE 2 DIABETES CARE: BRIDGING GAPS WITH PERSONALIZED, DIGITAL, AND LMIC-TAILORED INNOVATIONS – A SYSTEMATIC REVIEW

Type 2 diabetes (T2D) affects over 500 million people globally, with India facing 11-15% prevalence amid rapid urbanization and lifestyle shifts. while RCTs endorse low-glycemic index with Mediterranean low-carbohydrate and plant-based diets for HbA1c reductions of 0.5-1.2%, weight loss, and cardiovascular benefits. persistent gaps include poor long-term adherence (>40% dropout), unaffordable Low- and Middle-Income Countries adaptations (e.g., olive oil, nuts), and limited personalization for genetic/ethnic factors like key protein-coding gene located on chromosome 10q25.2–q25.3 variants. This PROSPERO-registered systematic review synthesizes 2023-2026 RCTs, network meta-analyses and cohorts (n>50 trials) from PubMed, Embase, Cochrane, and grey literature up to January 2026, evaluating glycaemic control, adherence, cost-effectiveness, and quality of life via GRADE-rated meta-analyses; LGI-Mediterranean hybrids excelled in Low- and Middle-Income Countries with digital interventions (apps, wearables) enhancing adherence by 25-35% through real-time feedback. We propose hybrid AI-driven models for Indian contexts—culturally adapted low-glycaemic index. plates featuring millets and lentils, pharmacogenomics-integrated mobile apps, and rural tele-counselling—leveraging predictive analytics for relapse prevention and pharmacoeconomic gains Incremental Cost-Effectiveness Ratio less than $500 per Quality-Adjusted Life Year), thereby bridging evidence-to-practice gaps with scalable, equity-focused innovations to mitigate Type 2 diabetes epidemic.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-03-16
DOI
https://doi.org/10.5281/zenodo.19081667
Primary Topic
Nutrition, Genetics, and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EVIDENCE-BASED NUTRITION PATTERNS AND LIFESTYLE COUNSELLING IN TYPE 2 DIABETES CARE: BRIDGING GAPS WITH PERSONALIZED, DIGITAL, AND LMIC-TAILORED INNOVATIONS – A SYSTEMATIC REVIEW

Pillarikuppam Pavani1, Anusha Konamsetti1, G. Bhavya1, D. Thilak1, Niraj Kumar1, Dr. Gangadhar Naik Jarupula2, Dr. D. Ravi Kiran2*
Zenodo (CERN European Organization for Nuclear Research)
Nutrition, Genetics, and Disease
article

EVIDENCE-BASED NUTRITION PATTERNS AND LIFESTYLE COUNSELLING IN TYPE 2 DIABETES CARE: BRIDGING GAPS WITH PERSONALIZED, DIGITAL, AND LMIC-TAILORED INNOVATIONS – A SYSTEMATIC REVIEW

Pillarikuppam Pavani1, Anusha Konamsetti1, G. Bhavya1, D. Thilak1, Niraj Kumar1, Dr. Gangadhar Naik Jarupula2, Dr. D. Ravi Kiran2*
article en

Abstract

Type 2 diabetes (T2D) affects over 500 million people globally, with India facing 11-15% prevalence amid rapid urbanization and lifestyle shifts. while RCTs endorse low-glycemic index with Mediterranean low-carbohydrate and plant-based diets for HbA1c reductions of 0.5-1.2%, weight loss, and cardiovascular benefits. persistent gaps include poor long-term adherence (>40% dropout), unaffordable Low- and Middle-Income Countries adaptations (e.g., olive oil, nuts), and limited personalization for genetic/ethnic factors like key protein-coding gene located on chromosome 10q25.2–q25.3 variants. This PROSPERO-registered systematic review synthesizes 2023-2026 RCTs, network meta-analyses and cohorts (n>50 trials) from PubMed, Embase, Cochrane, and grey literature up to January 2026, evaluating glycaemic control, adherence, cost-effectiveness, and quality of life via GRADE-rated meta-analyses; LGI-Mediterranean hybrids excelled in Low- and Middle-Income Countries with digital interventions (apps, wearables) enhancing adherence by 25-35% through real-time feedback. We propose hybrid AI-driven models for Indian contexts—culturally adapted low-glycaemic index. plates featuring millets and lentils, pharmacogenomics-integrated mobile apps, and rural tele-counselling—leveraging predictive analytics for relapse prevention and pharmacoeconomic gains Incremental Cost-Effectiveness Ratio less than $500 per Quality-Adjusted Life Year), thereby bridging evidence-to-practice gaps with scalable, equity-focused innovations to mitigate Type 2 diabetes epidemic.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 18%
Nutrition, Genetics, and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.